Swedish neurotech startup Flow Neuroscience has secured FDA approval for the first brain stimulation device for home use in ...
In a major shift for how mental health conditions might be treated, the US Food and Drug Administration (FDA) has approved ...
The FDA has approved Flow, a prescription home-use cranial electrotherapy stimulation device, for treating moderate to severe major depressive disorder (MDD) in adults aged 18 years and older.
A noninvasive, home-based brain treatment with transcranial direct current stimulation (tDCS) can reduce pain severity, improve pain-related disability, and enhance endogenous pain modulation in women ...
The U.S. Food and Drug Administration cleared Flow Neuroscience’s at-home electrical stimulation headset for adults with moderate-to-severe depression A trial of 174 people found the device led to ...
Please provide your email address to receive an email when new articles are posted on . High-definition transcranial direct current stimulation was well tolerated with mild adverse effects. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results